About Adolor (NASDAQ:ADLR)
Adolor Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pain and pain-management products. ENTEREG (alvimopan) is the United States Food and Drug Administration (FDA) approved product. ENTEREG is indicated to accelerate upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primary anastomosis. The Company is conducting two Phase 2 clinical trials of ADL5945 to treat opioid-induced constipation (OIC), a condition that often results from long-term use of opioid analgesics in the management of chronic pain conditions. In addition, it is continuing development efforts on ADL7445, a second peripherally-acting mu opioid receptor antagonist, which is considered a back-up compound in its OIC program. The Company has completed Phase 1 clinical evaluation of ADL6906 (beloxepin). In December 2011, Cubist Pharmaceuticals, Inc. acquired Adolor Corporation.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Adolor (NASDAQ:ADLR) Frequently Asked Questions
What is Adolor's stock symbol?
Adolor trades on the NASDAQ under the ticker symbol "ADLR."
Who are some of Adolor's key competitors?
Some companies that are related to Adolor include Johnson & Johnson (JNJ), Novartis (NVS), UnitedHealth Group (UNH), Pfizer (PFE), Roche (ROG), AbbVie (ABBV), Merck & Co., Inc. (MRK), Amgen (AMGN), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Abbott Laboratories (ABT), Sanofi (SNY), GlaxoSmithKline (GSK), Eli Lilly and (LLY), AstraZeneca (AZN), Bayer (BAYN), Sanofi (SAN) and Celgene (CELG).
How do I buy Adolor stock?
Shares of Adolor can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Adolor?
Adolor's mailing address is 700 Pennsylvania Dr, EXTON, PA 19341-1129, United States. The biopharmaceutical company can be reached via phone at +1-302-6587581.
MarketBeat Community Rating for Adolor (ADLR)MarketBeat's community ratings are surveys of what our community members think about Adolor and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Adolor (NASDAQ:ADLR) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Adolor (NASDAQ:ADLR) Earnings History and Estimates Chart
Adolor (NASDAQ ADLR) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Adolor (NASDAQ:ADLR) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Adolor (NASDAQ:ADLR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Adolor (NASDAQ ADLR)
No insider trades for this company have been tracked by MarketBeat.com
Adolor (NASDAQ ADLR) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Adolor (NASDAQ:ADLR) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Adolor (NASDAQ:ADLR) Income Statement, Balance Sheet and Cash Flow Statement
Adolor (NASDAQ ADLR) Stock Chart for Tuesday, February, 20, 2018